clinical-microbiology-biotechnology-2019-posters

15 / 17

allied
academies
Page 41
June 12-13, 2019 | Edinburgh, Scotland
8th European Clinical Microbiology and Immunology Congress
&
3rd World congress on Biotechnology
Joint Event
Microbiology: Current Research | Volume: 3 | ISSN: 2591-8036
Marine biotechnology as a support for the development of the blue bioeconomy in
the EU H2020 framework
Donatella de Pascale
Institute of Protein Biochemistry, Italy
The marine environment includes incredible biological
and chemical diversity, which are still largely unexploited.
Marine microorganisms possess secondary metabolites
that assist in survival and defence in these harsh habitats.
Particularly, marine resources are involved in added-value
products and processes in the food, cosmetic, pharmaceutical
and bioprocess industries. Bioprospecting for these natural
products are important to the EU Blue bioeconomy, which is
focused on creating employment, boosting economic growth,
and contributing to a healthier and sustainable society. Since,
the seas and oceans play a pivotal role in driving the EU
economy, its contribution to achieving the goals of the EU
H2020 strategy for smart, sustainable and inclusive growth
cannot be overlooked. However, additional growth can be
acquired by developing sectors that have a high potential for
sustainable jobs and growth. To fully exploit these promising
biological resources, new strategies in the pipeline as well as a
new cohort of cross-disciplinary trained scientists are needed
to overcome existing bottlenecks for the production of high
value biomolecules.
Donatella de Pascale is the coordinator of the following
H2020-MSCA projects:
The H2020-MSCA-ITN-ETN: MarPipe is a Research and
Training Network program of 11 academic and industrial
partners based in 8 European countries working in
collaboration to train 11 Early stage researchers in the field
of marine drug-discovery focused on antimicrobials and
anticancer compounds. The H2020-MSCA-RISE: Ocean
Medicines is a network of academic and SMEs across
Europe and Africa, with proven experience in training
and endowed with state-of-the art scientific and technical
expertise and infrastructures, aimed at fostering young
marine biodiscovery scientists from the development
of a new drug to its commercialization, innovation and
possibilities of entrepreneurship. A general overview of
the major achievements obtained from these two project
will be given in order to highlight the recent progress in
this field.
e:
Microbiol Curr Res, Volume 3
ISSN: 2591-8036
Notes: